Kane Biotech Inc. Release: A New Study Shows DispersinB(TM) Helps Our Body’s Immune Cells to Kill Bacteria

WINNIPEG, MANITOBA--(Marketwire - July 02, 2008) - Kane Biotech Inc. (TSX VENTURE: KNE), a biotechnology company engaged in the development of products that prevent and remove microbial biofilms, is pleased to announce a research publication on its DispersinB™ technology. The manuscript appeared in the recent online edition of Microbial Pathogenesis (2008), doi: 10/1016/j.micpath.2008.05.007.